[Indications and limitations of corticotherapy in the treatment of rhinitis and bronchial asthma syndromes].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001249:Asthma / Q000188:drug therapy*; D001623:Betamethasone / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010248:Paramethasone / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*; D014221:Triamcinolone / Q000627:therapeutic use
D005938:Glucocorticoids; D014221:Triamcinolone; D001623:Betamethasone; D011239:Prednisolone; D011241:Prednisone; D010248:Paramethasone
Indicazioni e limiti della corticoterapia nel trattamento delle sindromi rinitiche ed asmatico-bronchiali.